Mexico - Delayed Quote MXN

Atossa Therapeutics, Inc. (ATOS.MX)

15.50
+2.50
+(19.23%)
At close: April 24 at 12:18:44 PM CST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
27,621
27,621
--
27,691
20,521
Operating Income
-27,621
-27,621
--
-27,691
-20,521
Net Non Operating Interest Income Expense
4,050
4,050
--
877
6
Other Income Expense
-1,933
-1,933
--
-146
-91
Pretax Income
-25,504
-25,504
--
-26,960
-20,606
Net Income Common Stockholders
-25,504
-25,504
--
-26,960
-20,606
Diluted NI Available to Com Stockholders
-25,504
-25,504
--
-26,960
-20,606
Basic EPS
-0.20
-0.20
-0.24
-0.21
-0.18
Diluted EPS
-0.20
-0.20
-0.24
-0.21
-0.18
Basic Average Shares
125,859.28
125,859.28
126,081.60
126,624
116,950
Diluted Average Shares
125,859.28
125,859.28
126,081.60
126,624
116,950
Total Operating Income as Reported
-27,621
-27,621
--
-27,691
-20,521
Total Expenses
27,621
27,621
--
27,691
20,521
Net Income from Continuing & Discontinued Operation
-25,504
-25,504
--
-26,960
-20,606
Normalized Income
-23,794
-23,794
--
-26,960
-20,606
Interest Income
4,050
4,050
--
877
6
Net Interest Income
4,050
4,050
--
877
6
EBIT
-27,621
-27,621
--
-27,691
-20,521
EBITDA
-27,604
-27,604
--
-27,683
-20,498
Reconciled Depreciation
17
17
--
8
23
Net Income from Continuing Operation Net Minority Interest
-25,504
-25,504
--
-26,960
-20,606
Total Unusual Items Excluding Goodwill
-1,710
-1,710
--
--
--
Total Unusual Items
-1,710
-1,710
--
--
--
Normalized EBITDA
-25,894
-25,894
--
-27,683
-20,498
12/31/2021 - 11/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GNFT Genfit S.A.
3.6700
-2.65%
 
FBRX Forte Biosciences, Inc.
6.96
+15.04%
 
ENVB Enveric Biosciences, Inc.
1.3348
+3.47%
 
KALA KALA BIO, Inc.
3.3000
+5.77%
 
BLUE bluebird bio, Inc.
4.1600
+1.71%
 
PHIO Phio Pharmaceuticals Corp.
2.2300
+9.31%
 
CAPR Capricor Therapeutics, Inc.
13.28
+0.99%
 
VXRT Vaxart, Inc.
0.3600
+4.74%
 
INO Inovio Pharmaceuticals, Inc.
1.9200
+2.67%
 
PSTV Plus Therapeutics, Inc.
0.8427
-14.32%